ADR120S

ADR120S EBIT Margin

The EBIT Margin (Operating Margin) of ADR120S (3750.T) as of Nov 3, 2026 is -1,777.23 %. In the previous year, EBIT Margin (Operating Margin) was -660.28 % — a change of 169.16% (lower).

EBIT Margin

-1,777.23 %

YoY

169.16%

Last updated:

EBIT Margin (Operating Margin) of ADR120S is 2026 -1,777.23 % . EBIT Margin (Operating Margin) of ADR120S was 2025 -660.28 % . It decreases by 169.16% lower compared to the previous year.

For ADR120S, the operating (EBIT) margin of -1,777.2% is down versus -34.6% a few years ago.

The ADR120S EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
17.16 JPY
Jan 1, 2020
31.92 JPY
Jan 1, 2021
-52.70 JPY
Jan 1, 2022
-34.62 JPY
Jan 1, 2023
-37.04 JPY
Jan 1, 2024
-49.52 JPY
Jan 1, 2025
-660.28 JPY
Jan 1, 2026
-1,777.23 JPY
The ADR120S EBIT Margin history
YEAREBIT MarginYoY
-1,777.23 %+169.16%
-660.28 %+1,233.29%
-49.52 %+33.71%
-37.04 %+7.00%
-34.62 %-34.32%
-52.70 %-265.09%
31.92 %+86.07%
17.16 %-35.21%
26.48 %-278.97%
-14.80 %+63.01%
-9.08 %-190.45%
10.03 %+10.82%
9.06 %-37,175.10%
-0.02 %+166.76%
-0.01 %+160.51%
-0.00-90.88%
-0.04 %+22.77%
-0.03 %+16.55%
-0.03 %-21,463.60%
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ADR120S Stock analysis

What does ADR120S do? ADR120S Inc generates revenue through its Real Asset segment, which involves buying and selling real estate, developing and operating hotels, and investing in real estate projects. The Medical segment focuses on regenerative medicine, selling medical equipment like the Celusion centrifuge and Celusion cell therapy kit, and providing cell therapy services. The company serves clients in real estate development, hotel operations, and healthcare sectors, with products targeting medical facilities and clinics specializing in regenerative treatments. The Real Asset segment handles property transactions, hotel management, and real estate investments, while the Medical segment offers cell therapy solutions through its branded products. Both segments target businesses seeking to expand in real estate or adopt advanced medical technologies, with the Celusion products being key revenue drivers in the healthcare market. ADR120S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADR120S stock

EBIT Margin (Operating Margin) of ADR120S is -1,777.23 % in 2026.

EBIT Margin (Operating Margin) of ADR120S changed from -660.28 % to -1,777.23 %, representing a 169.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) ADR120S since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s ADR120S with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — ADR120S

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — ADR120S